| Name | Title | Contact Details |
|---|
Cambia Health Solutions is a nonprofit health care company based in Portland, Oregon. It is committed to making health care simpler, better, and more affordable while focusing on person-centered care. Serving over 3.6 million people through its regional health plans, Cambia also reaches millions of Americans as the parent company of various subsidiaries and through investments in over 20 health care companies across the U.S. Founded in 1917, Cambia has evolved significantly, rebranding from The Regence Group in 2013. The company emphasizes innovation, supporting health care startups through its Cambia Grove innovation hub. Cambia operates several regional health plans, including Regence, Asuris Northwest Health, BridgeSpan Health, and LifeMap, which provide personalized health care experiences. Additionally, Cambia invests in digital health and consumer-focused companies, enhancing its commitment to improving health care access and quality.
Greenside Up Inc is a Greenland, NH-based company in the Business Services sector.
CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.
Henderson Consulting is a New Richmond, WI-based company in the Business Services sector.
Bill's Blueprint Inc is a Everett, WA-based company in the Business Services sector.